| J9271 | Injection, pembrolizumab, 1 mg | 6,400 | $40 | $275.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 810 | $90 | $74K |
| J0897 | Injection, denosumab, 1 mg | 2,820 | $20 | $50.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 320 | $60 | $20.3K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,300 | $1 | $18.6K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 110 | $160 | $17.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 140 | $110 | $15K |
| J3490 | Unclassified drugs | 30 | $410 | $12.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 100 | $120 | $12K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 60 | $140 | $7.7K |